TTM TECHNOLOGIES INC — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that TTM TECHNOLOGIES INC filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 29, 2025 | $2.91B | Feb 17, 2026 |
| FY2025 | Dec 30, 2024 | $2.44B | Feb 17, 2026 |
| FY2025 | Jan 1, 2024 | $2.23B | Feb 17, 2026 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 29, 2025 | $2.91B | Feb 17, 2026 |
| FY2025 | Dec 30, 2024 | $2.44B | Feb 17, 2026 |
| FY2025 | Jan 1, 2024 | $2.23B | Feb 17, 2026 |
| FY2024 | Jan 2, 2023 | $2.50B | Feb 21, 2025 |
| FY2024 | Jan 3, 2022 | $2.25B | Feb 27, 2024 |
| FY2023 | Dec 28, 2020 | $2.11B | Mar 3, 2023 |
| FY2021 | Dec 30, 2019 | $2.13B | Mar 1, 2022 |
| FY2020 | Dec 31, 2018 | $2.24B | Feb 22, 2021 |
| FY2019 | Jan 1, 2018 | $2.66B | Feb 26, 2020 |
| FY2018 | Jan 2, 2017 | $2.53B | Feb 26, 2019 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 29, 2025 | $601.69M | Feb 17, 2026 |
| FY2025 | Dec 30, 2024 | $477.38M | Feb 17, 2026 |
| FY2025 | Jan 1, 2024 | $413.27M | Feb 17, 2026 |
| FY2024 | Jan 2, 2023 | $457.97M | Feb 21, 2025 |
| FY2024 | Jan 3, 2022 | $372.01M | Feb 27, 2024 |
| FY2023 | Dec 28, 2020 | $359.02M | Mar 3, 2023 |
| FY2021 | Dec 30, 2019 | $377.18M | Mar 1, 2022 |
| FY2020 | Dec 31, 2018 | $402.67M | Feb 22, 2021 |
| FY2019 | Jan 1, 2018 | $429.58M | Feb 26, 2020 |
| FY2018 | Jan 2, 2017 | $423.62M | Feb 26, 2019 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 29, 2025 | $177.45M | Feb 17, 2026 |
| FY2025 | Dec 30, 2024 | $56.30M | Feb 17, 2026 |
| FY2025 | Jan 1, 2024 | ($18.72M) | Feb 17, 2026 |
| FY2024 | Jan 2, 2023 | $94.58M | Feb 21, 2025 |
| FY2024 | Jan 3, 2022 | $54.41M | Feb 27, 2024 |
| FY2023 | Dec 28, 2020 | $177.54M | Mar 3, 2023 |
| FY2021 | Dec 30, 2019 | $41.30M | Mar 1, 2022 |
| FY2020 | Dec 31, 2018 | $173.58M | Feb 22, 2021 |
| FY2019 | Jan 1, 2018 | $124.21M | Feb 26, 2020 |
| FY2018 | Jan 2, 2017 | $34.86M | Feb 26, 2019 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 29, 2025 | $264.68M | Feb 17, 2026 |
| FY2025 | Dec 30, 2024 | $116.04M | Feb 17, 2026 |
| FY2025 | Jan 1, 2024 | $42.32M | Feb 17, 2026 |
| FY2024 | Jan 2, 2023 | $210.41M | Feb 21, 2025 |
| FY2024 | Jan 3, 2022 | $125.99M | Feb 27, 2024 |
| FY2023 | Dec 28, 2020 | $28.09M | Mar 3, 2023 |
| FY2021 | Dec 30, 2019 | $109.63M | Mar 1, 2022 |
| FY2020 | Dec 31, 2018 | $118.97M | Feb 22, 2021 |
| FY2019 | Jan 1, 2018 | $212.76M | Feb 26, 2020 |
| FY2018 | Jan 2, 2017 | $173.45M | Feb 26, 2019 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 29, 2025 | $28.99M | Feb 17, 2026 |
| FY2025 | Dec 30, 2024 | $31.85M | Feb 17, 2026 |
| FY2025 | Jan 1, 2024 | $27.27M | Feb 17, 2026 |
| FY2024 | Jan 2, 2023 | $24.81M | Feb 21, 2025 |
| FY2024 | Jan 3, 2022 | $18.15M | Feb 27, 2024 |
| FY2023 | Dec 28, 2020 | $19.77M | Mar 3, 2023 |
| FY2021 | Dec 30, 2019 | $17.94M | Mar 1, 2022 |
| FY2020 | Dec 31, 2018 | $13.72M | Feb 22, 2021 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 29, 2025 | $291.88M | Feb 17, 2026 |
| FY2025 | Dec 30, 2024 | $236.89M | Feb 17, 2026 |
| FY2025 | Jan 1, 2024 | $187.28M | Feb 17, 2026 |
| FY2024 | Jan 2, 2023 | $272.87M | Feb 21, 2025 |
| FY2024 | Jan 3, 2022 | $176.63M | Feb 27, 2024 |
| FY2023 | Dec 28, 2020 | $287.18M | Mar 3, 2023 |
| FY2021 | Dec 30, 2019 | $311.94M | Mar 1, 2022 |
| FY2020 | Dec 31, 2018 | $273.14M | Feb 22, 2021 |
| FY2019 | Jan 1, 2018 | $332.76M | Feb 26, 2020 |
| FY2018 | Jan 2, 2017 | $298.34M | Feb 26, 2019 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 29, 2025 | $292.57M | Feb 17, 2026 |
| FY2025 | Dec 30, 2024 | $185.74M | Feb 17, 2026 |
| FY2025 | Jan 1, 2024 | $160.24M | Feb 17, 2026 |
| FY2024 | Jan 2, 2023 | $102.88M | Feb 21, 2025 |
| FY2024 | Jan 3, 2022 | $81.95M | Feb 27, 2024 |
| FY2023 | Dec 28, 2020 | $103.29M | Mar 3, 2023 |
| FY2021 | Dec 30, 2019 | $142.58M | Mar 1, 2022 |
| FY2020 | Dec 31, 2018 | $150.13M | Feb 22, 2021 |
| FY2019 | Jan 1, 2018 | $151.35M | Feb 26, 2020 |
| FY2018 | Jan 2, 2017 | $85.14M | Feb 26, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 29, 2025 | $3.84B | Feb 17, 2026 |
| FY2025 | Dec 30, 2024 | $3.47B | Feb 17, 2026 |
| FY2024 | Jan 1, 2024 | $3.32B | Feb 21, 2025 |
| FY2024 | Jan 2, 2023 | $3.32B | Feb 27, 2024 |
| FY2023 | Jan 3, 2022 | $3.03B | Mar 3, 2023 |
| FY2021 | Dec 28, 2020 | $2.90B | Mar 1, 2022 |
| FY2020 | Dec 30, 2019 | $3.56B | Feb 22, 2021 |
| FY2019 | Dec 31, 2018 | $3.46B | Feb 26, 2020 |
| FY2019 | Jan 1, 2018 | $2.78B | Feb 26, 2020 |
| FY2018 | Jan 2, 2017 | $2.50B | Feb 26, 2019 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 29, 2025 | $1.76B | Feb 17, 2026 |
| FY2025 | Dec 30, 2024 | $1.56B | Feb 17, 2026 |
| FY2025 | Jan 1, 2024 | $1.51B | Feb 17, 2026 |
| FY2025 | Jan 2, 2023 | $1.54B | Feb 17, 2026 |
| FY2024 | Jan 3, 2022 | $1.46B | Feb 21, 2025 |
| FY2024 | Dec 28, 2020 | $1.44B | Feb 27, 2024 |
| FY2023 | Dec 30, 2019 | $1.28B | Mar 3, 2023 |
| FY2021 | Dec 31, 2018 | $1.23B | Mar 1, 2022 |
| FY2020 | Jan 1, 2018 | $1.01B | Feb 22, 2021 |
| FY2017 | Jan 2, 2017 | $820.85M | Feb 23, 2018 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 29, 2025 | $670.14M | Feb 17, 2026 |
| FY2025 | Dec 30, 2024 | $670.14M | Feb 17, 2026 |
| FY2024 | Jan 1, 2024 | $702.74M | Feb 21, 2025 |
| FY2024 | Jan 2, 2023 | $760.44M | Feb 27, 2024 |
| FY2023 | Jan 3, 2022 | $637.32M | Mar 3, 2023 |
| FY2021 | Dec 28, 2020 | $637.32M | Mar 1, 2022 |
| FY2021 | Dec 30, 2019 | $706.52M | Mar 1, 2022 |
| FY2020 | Dec 31, 2018 | $698.78M | Feb 22, 2021 |
| FY2019 | Jan 1, 2018 | $372.57M | Feb 26, 2020 |
| FY2018 | Jan 2, 2017 | $372.61M | Feb 26, 2019 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 29, 2025 | $1.02B | Feb 17, 2026 |
| FY2025 | Dec 30, 2024 | $838.42M | Feb 17, 2026 |
| FY2024 | Jan 1, 2024 | $782.12M | Feb 21, 2025 |
| FY2024 | Jan 2, 2023 | $800.84M | Feb 27, 2024 |
| FY2023 | Jan 3, 2022 | $706.26M | Mar 3, 2023 |
| FY2021 | Dec 28, 2020 | $651.84M | Mar 1, 2022 |
| FY2020 | Dec 30, 2019 | $474.31M | Feb 22, 2021 |
| FY2019 | Dec 31, 2018 | $433.01M | Feb 26, 2020 |
| FY2018 | Jan 1, 2018 | $230.85M | Feb 26, 2019 |
| FY2017 | Jan 2, 2017 | $74.79M | Feb 23, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 29, 2025 | $501.23M | Feb 17, 2026 |
| FY2025 | Dec 30, 2024 | $503.93M | Feb 17, 2026 |
| FY2024 | Jan 1, 2024 | $450.21M | Feb 21, 2025 |
| FY2024 | Jan 2, 2023 | $402.75M | Feb 27, 2024 |
| FY2023 | Jan 3, 2022 | $537.68M | Mar 3, 2023 |
| FY2021 | Dec 28, 2020 | $451.57M | Mar 1, 2022 |
| FY2020 | Dec 30, 2019 | $379.82M | Feb 22, 2021 |
| FY2019 | Dec 31, 2018 | $256.36M | Feb 26, 2020 |
| FY2018 | Jan 1, 2018 | $409.33M | Feb 26, 2019 |
| FY2018 | Jan 2, 2017 | $256.28M | Feb 26, 2019 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 29, 2025 | $916.15M | Feb 17, 2026 |
| FY2025 | Dec 30, 2024 | $918.15M | Feb 17, 2026 |
| FY2016 | Jan 2, 2017 | $1.02B | Feb 24, 2017 |
| FY2016 | Dec 28, 2015 | $1.17B | Feb 24, 2017 |
| FY2015 | Dec 29, 2014 | $502.69M | Feb 25, 2016 |
| FY2014 | Dec 30, 2013 | $370.01M | Feb 27, 2015 |
| FY2013 | Dec 31, 2012 | $400.01M | Feb 21, 2014 |
| FY2012 | Dec 31, 2011 | $338.25M | Mar 1, 2013 |
| FY2011 | Dec 31, 2010 | $380.12M | Feb 29, 2012 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 29, 2025 | 1 | Feb 17, 2026 |
| FY2025 | Dec 30, 2024 | 0 | Feb 17, 2026 |
| FY2025 | Jan 1, 2024 | 0 | Feb 17, 2026 |
| FY2024 | Jan 2, 2023 | 0 | Feb 21, 2025 |
| FY2024 | Jan 3, 2022 | 0 | Feb 27, 2024 |
| FY2023 | Dec 28, 2020 | 1 | Mar 3, 2023 |
| FY2021 | Dec 30, 2019 | 0 | Mar 1, 2022 |
| FY2020 | Dec 31, 2018 | 1 | Feb 22, 2021 |
| FY2019 | Jan 1, 2018 | 1 | Feb 26, 2020 |
| FY2018 | Jan 2, 2017 | 0 | Feb 26, 2019 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 29, 2025 | 1 | Feb 17, 2026 |
| FY2025 | Dec 30, 2024 | 0 | Feb 17, 2026 |
| FY2025 | Jan 1, 2024 | 0 | Feb 17, 2026 |
| FY2024 | Jan 2, 2023 | 0 | Feb 21, 2025 |
| FY2024 | Jan 3, 2022 | 0 | Feb 27, 2024 |
| FY2023 | Dec 28, 2020 | 1 | Mar 3, 2023 |
| FY2021 | Dec 30, 2019 | 0 | Mar 1, 2022 |
| FY2020 | Dec 31, 2018 | 1 | Feb 22, 2021 |
| FY2019 | Jan 1, 2018 | 1 | Feb 26, 2020 |
| FY2018 | Jan 2, 2017 | 0 | Feb 26, 2019 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 29, 2025 | 103.38M | Feb 17, 2026 |
| FY2025 | Dec 30, 2024 | 102.00M | Feb 17, 2026 |
| FY2024 | Jan 1, 2024 | 102.11M | Feb 21, 2025 |
| FY2024 | Jan 2, 2023 | 102.23M | Feb 27, 2024 |
| FY2023 | Jan 3, 2022 | 103.53M | Mar 3, 2023 |
| FY2021 | Dec 28, 2020 | 106.77M | Mar 1, 2022 |
| FY2020 | Dec 30, 2019 | 105.51M | Feb 22, 2021 |
| FY2019 | Dec 31, 2018 | 103.69M | Feb 26, 2020 |
| FY2018 | Jan 1, 2018 | 101.82M | Feb 26, 2019 |
| FY2017 | Jan 2, 2017 | 100.40M | Feb 23, 2018 |